Please login to the form below

Not currently logged in
Email:
Password:

myeloma

This page shows the latest myeloma news and features for those working in and with pharma, biotech and healthcare.

NICE partially clears Darzalex combo in blood cancer

NICE partially clears Darzalex combo in blood cancer

Despite the limited data, the committee said the treatment was a potential “game-changer” for those with relapsed multiple myeloma after it evaluated the drug’s efficacy. ... Myeloma is an increasingly dynamic and competitive therapy class, with

Latest news

More from news
Approximately 66 fully matching, plus 201 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics